Hers vs LIV by WellNow
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mainstream telehealth GLP-1 access.
- semaglutide
- From $199/molowest dose rung
- tirzepatide
- $299/mobrand-name
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Before enrolling
Limited public information on program details
Desk Score
Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.
- semaglutide
- From $195/molowest dose rung
- tirzepatide
- Not confirmed for LIV by WellNow.
Before enrolling
The price follows the DOSE: $195/month covers the average 1 mg dose, but 1.7 mg or 2.4 mg costs $265/month, and the headline says "no hidden fees"
Our review of Hers gives it 76/100 (C), while our review of LIV by WellNow gives it 71/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
76/100
C
71/100
C
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Hers | LIV by WellNow |
|---|---|---|
| Semaglutide | From $199/molowest dose rungFull plan terms$199/mo (starting dose, compounded) | From $195/molowest dose rungFull plan terms$195/mo month-to-month (compounded, at the average 1 mg dose); $175/mo paid quarterly · higher doses of 1.7 mg or 2.4 mg are $265/mo, or $249/mo paid quarterly |
| Tirzepatide | $299/mobrand-nameFull plan terms$299/mo (starting dose, plus a separate fee, brand-name) | Not confirmed for LIV by WellNow. |
| Coverage | All 50 states | 5 states (IL, IN, MI, NY, PA) |
| Brand-name | Brand-name option listed | Brand-name option listed |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Mainstream telehealth GLP-1 access. | Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung. |
| Desk Score | 76/100C | 71/100C |
The verdict
Desk pick — HersHers has the higher Desk Score, but LIV by WellNow may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Mainstream telehealth GLP-1 access.
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Patients in IL, IN, MI, NY, or PA who want all-inclusive compounded semaglutide from a company with physical clinics behind it, and who have budgeted for the higher-dose rung.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Hers
- CoreAge Rx vs LIV by WellNow
- Eden vs Hers
- LIV by WellNow vs Sesame Care
- Hers vs Vytora Health
- Eden vs LIV by WellNow
Or see the full comparison hub and the complete ranking.